ERN PaedCan
European Reference Network for Paediatric Oncology
Children and adolescents with cancer
deserve the best possible healthcare –
no matter where they live
For Healthcare professionals
For Patients
and Families
The Clinical Patient
Management System (CPMS)
News, Events
and Publications
Collaborations
ERN PaedCan works closely with EU projects to expand knowledge and improve care for rare diseases.
Support Ukraine
Coordinating efforts to transfer young cancer patients to specialized centres in Europe.
Our Goals
Reduce inequalities
Reduce inequalities across Member States by enabling access to up to date diagnostics and treatments by facilitating the exchange of knowledge and expertise.
Information travels
Information travels rather than the patients through the implementation of Virtual Tumour Boards.
Cross-border healthcare
Cross-border healthcare to unite specialists across Europe and thus tackle complex or rare cancer conditions that require highly specialised interventions and a concentration of knowledge and resources.
THE EUROPEAN REFERENCE NETWORKS
ERN PAEDCAN MEMBERS
90
Total number of members
79
Full Members from
21 countries
11
Affiliated Partners from
7 countries
Upcoming Events
-
High-Level Meeting on a European Research and Innovation Ecosystem for Rare Diseases
The High-Level Meeting (HLM)on a European research and Innovation ecosystem for rare diseases will take place on December 9-11, 2025 in Brussels.This three-day event will gather key stakeholders, including EU policymakers, industry leaders, patient advocacy groups, researchers, and healthcare providers. The goal is to identify concrete actions and incentives to enhance innovation across the rare… Read more
-
6th International Symposium for Childhood Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL)
The 6th International Symposium for Childhood Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL) will take place in Berlin, Germany, October 15-18,2025. The symposium target audience: Scientists and clinicians involved in the research and treatment of Hodgkin lymphoma in children, adolescents, and young adults. The Focus areas: Survivorship outcomes, global clinical trial portfolios, novel therapeutic biomarkers, advances in… Read more